Intuitive Surgical (NASDAQ: ISRG) reported Q4 EPS of $2.53, $0.27 better than the analyst estimate of $2.26. Revenue for the quarter came in at $2.87 billion versus the consensus estimate of $2.75 billion.

2026 Financial Outlook

• The Company expects the following results for the full year of 2026:
• Worldwide da Vinci procedure growth of approximately 13% to 15% in 2026, compared to 18% in 2025.
• Non-GAAP* gross profit margin to be within a range of 67% and 68% of revenue in 2026, compared to 67.6% in 2025. This range includes an estimated impact from tariffs of 1.2% of revenue, plus or minus 10 basis points.
• Non-GAAP* operating expense growth of 11% to 15% in 2026, compared to 12% in 2025.

For earnings history and earnings-related data on Intuitive Surgical (ISRG) click here.